Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2013 | 33 | 5 | 341-348
Tytuł artykułu

Pomegranate and type 2 diabetes

Treść / Zawartość
Abstrakt, słowa kluczowe
Dodatkowe informacje
Warianty tytułu
Języki publikacji
Over the last decade, various studies have linked pomegranate (Punica granatum Linn), a fruit native to the Middle East, with type 2 diabetes prevention and treatment. This review focuses on current laboratory and clinical research related to the effects of pomegranate fractions (peels, flowers, and seeds) and some of their active components on biochemical and metabolic variables associated with the pathologic markers of type 2 diabetes. This review systematically presents findings from cell culture and animal studies as well as clinical human research. One key mechanism by which pomegranate fractions affect the type 2 diabetic condition is by reducing oxidative stress and lipid peroxidation. This reduction may occur by directly neutralizing the generated reactive oxygen species, increasing certain antioxidant enzyme activities, inducing metal chelation activity, reducing resistin formation, and inhibiting or activating certain transcriptional factors, such as nuclear factor κB and peroxisome proliferator–activated receptor γ. Fasting blood glucose levels were decreased significantly by punicic acid, methanolic seed extract, and pomegranate peel extract. Known compounds in pomegranate, such as punicalagin and ellagic, gallic, oleanolic, ursolic, and uallic acids, have been identified as having anti-diabetic actions. Furthermore, the juice sugar fraction was found to have unique antioxidant polyphenols (tannins and anthocyanins), which could be beneficial to control conditions in type 2 diabetes. These findings provide evidence for the anti-diabetic activity of pomegranate fruit; however, before pomegranate or any of its extracts can be medically recommended for the management of type 2 diabetes, controlled, clinical studies, are needed.
Nutrition Research , ISSN 02715317
Opis fizyczny
  • Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan ,
  • Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan
  • King Hussein Medical Center, Jordanian Royal Medical Services, Amman, Jordan
  • 1. Johanningsmeier, S.D.& Harris, G.K., "Pomegranate as a functional food and nutraceutical source", Annu Rev Food Sci Technol, vol. 2, 2011, p.181-201
  • 2. Das, A.K.& Mandal, S.C.& Banerjee, S.K.& Sinha, S.& Saha, B.P.& Pal, M., "Studies on the hypoglycaemic activity of Punica granatum seed in streptozotocin induced diabetic rats", Phytother Res, vol. 15, 2001, p.628-629
  • 3. Jurenka, J.S., "Therapeutic applications of pomegranate (Punica granatum L.): a review", Altern Med Rev, vol. 13, 2008, p.128-144
  • 4. Medjakovic, S.& Jungbauer, A., "Pomegranate: a fruit that ameliorates metabolic syndrome", Food Funct, vol. 4, 2013, p.19-39
  • 5. Ismail, T.& Sestili, P.& Akhtar, S., "Pomegranate peel and fruit extracts: a review of potential anti-inflammatory and anti-infective effects", J Ethnopharmacol, vol. 143, 2012, p.397-405
  • 6. Trottier, G.& Bostrom, P.J.& Lawrentschuk, N.& Fleshner, N.E., "Nutraceuticals and prostate cancer prevention: a current review", Nat Rev Urol, vol. 7, 2010, p.21-30
  • 7. Katz, S.R.& Newman, R.A.& Lansky, E.P., "Punica granatum: heuristic treatment for diabetes mellitus", J Med Food, vol. 10, 2007, p.213-217
  • 8. Basu, A.& Penugonda, K., "Pomegranate juice: a heart-healthy fruit juice", Nutr Rev, vol. 67, 2009, p.49-56
  • 9. Li, N.& Karin, M., "Is NF-kappaB the sensor of oxidative stress?", FASEB J, vol. 13, 1999, p.1137-1143
  • 10. Schubert, S.Y.& Neeman, I.& Resnick, N., "A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants", FASEB J, vol. 16, 2002, p.1931-1933
  • 11. Aggarwal, B.B.& Shishodia, S., "Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning", Ann N Y Acad Sci, vol. 1030, 2004, p.434-441
  • 12. Huang, T.H.& Peng, G.& Kota, B.P.& Li, G.Q.& Yamahara, J.& Roufogalis, B.D. et al., "Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component", Toxicol Appl Pharmacol, vol. 207, 2005, p.160-169
  • 13. Parmar, H.S.& Kar, A., "Medicinal values of fruit peels from Citrus sinensis, Punica granatum, and Musa paradisiaca with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones", J Med Food, vol. 11, 2008, p.376-381
  • 14. Hontecillas, R.& O'Shea, M.& Einerhand, A.& Diguardo, M.& Bassaganya-Riera, J., "Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation", J Am Coll Nutr, vol. 28, 2009, p.184-195
  • 15. Koren-Gluzer, M.& Aviram, M.& Meilin, E.& Hayek, T., "The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates beta-cell insulin release", Atherosclerosis, vol. 219, 2011, p.510-518
  • 16. Makino-Wakagi, Y.& Yoshimura, Y.& Uzawa, Y.& Zaima, N.& Moriyama, T.& Kawamura, Y., "Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes", Biochem Biophys Res Commun, vol. 417, 2012, p.880-885
  • 17. Parmar, H.S.& Kar, A., "Antidiabetic potential of Citrus sinensis and Punica granatum peel extracts in alloxan treated male mice", Biofactors, vol. 31, 2007, p.17-24
  • 18. Wang, J.& Rong, X.& Um, I.S.& Yamahara, J.& Li, Y., "55-week treatment of mice with the unani and ayurvedic medicine pomegranate flower ameliorates ageing-associated insulin resistance and skin abnormalities", Evid Based Complement Alternat Med, vol. 2012, 2012, p.350125
  • 19. Jafri, M.A.& Aslam, M.& Javed, K.& Singh, S., "Effect of Punica granatum Linn. (flowers) on blood glucose level in normal and alloxan-induced diabetic rats", J Ethnopharmacol, vol. 70, 2000, p.309-314
  • 20. Huang, T.H.& Peng, G.& Kota, B.P.& Li, G.Q.& Yamahara, J.& Roufogalis, B.D. et al., "Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids", Br J Pharmacol, vol. 145, 2005, p.767-774
  • 21. Huang, T.H.& Yang, Q.& Harada, M.& Li, G.Q.& Yamahara, J.& Roufogalis, B.D. et al., "Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways", J Cardiovasc Pharmacol, vol. 46, 2005, p.856-862
  • 22. Bagri, P.& Ali, M.& Aeri, V.& Bhowmik, M.& Sultana, S., "Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes", Food Chem Toxicol, vol. 47, 2009, p.50-54
  • 23. Xu, K.Z.& Zhu, C.& Kim, M.S.& Yamahara, J.& Li, Y., "Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity", J Ethnopharmacol, vol. 123, 2009, p.280-287
  • 24. Pirbalouti, A.G.& Azizi, S.& Koohpayeh, A.& Hamedi, B., "Wound healing activity of Malva sylvestris and Punica granatum in alloxan-induced diabetic rats", Acta Pol Pharm, vol. 67, 2010, p.511-516
  • 25. Cambay, Z.& Baydas, G.& Tuzcu, M.& Bal, R., "Pomegranate (Punica granatum L.) flower improves learning and memory performances impaired by diabetes mellitus in rats", Acta Physiol Hung, vol. 98, 2011, p.409-420
  • 26. Jelodar, G.& Mohsen, M.& Shahram, S., "Effect of walnut leaf, coriander and pomegranate on blood glucose and histopathology of pancreas of alloxan induced diabetic rats", Afr J Tradit Complement Altern Med, vol. 4, 2007, p.299-305
  • 27. McFarlin, B.K.& Strohacker, K.A.& Kueht, M.L., "Pomegranate seed oil consumption during a period of high-fat feeding reduces weight gain and reduces type 2 diabetes risk in CD-1 mice", Br J Nutr, vol. 102, 2009, p.54-59
  • 28. Krueger, D.A., "Composition of pomegranate juice", J AOAC Int, vol. 95, 2012, p.163-168
  • 29. Fischer, U.A.& Carle, R.& Kammerer, D.R., "Identification and quantification of phenolic compounds from pomegranate (Punica granatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI/MS(n)", Food Chem, vol. 127, 2011, p.807-821
  • 30. Sartippour, M.R.& Seeram, N.P.& Rao, J.Y.& Moro, A.& Harris, D.M.& Henning, S.M. et al., "Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo", Int J Oncol, vol. 32, 2008, p.475-480
  • 31. Seeram, N.P.& Zhang, Y.& McKeever, R.& Henning, S.M.& Lee, R.P.& Suchard, M.A. et al., "Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects", J Med Food, vol. 11, 2008, p.390-394
  • 32. de Pascual-Teresa, S.& Santos-Buelga, C.& Rivas-Gonzalo, J.C., "Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages", J Agric Food Chem, vol. 48, 2000, p.5331-5337
  • 33. Gil, M.I.& Tomas-Barberan, F.A.& Hess-Pierce, B.& Holcroft, D.M.& Kader, A.A., "Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing", J Agric Food Chem, vol. 48, 2000, p.4581-4589
  • 34. Mena, P.& Galindo, A.& Collado-Gonzalez, J.& Ondono, S.& Garcia-Viguera, C.& Ferreres, F. et al., "Sustained deficit irrigation affects the colour and phytochemical characteristics of pomegranate juice", J Sci Food Agric, 2012, [Epub ahead of print].
  • 35. Fuhrman, B.& Volkova, N.& Aviram, M., "Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: studies in vitro and in diabetic patients", Nutrition, vol. 26, 2010, p.359-366
  • 36. Rock, W.& Rosenblat, M.& Miller-Lotan, R.& Levy, A.P.& Elias, M.& Aviram, M., "Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities", J Agric Food Chem, vol. 56, 2008, p.8704-8713
  • 37. Afaq, F.& Zaid, M.A.& Khan, N.& Dreher, M.& Mukhtar, H., "Protective effect of pomegranate-derived products on UVB-mediated damage in human reconstituted skin", Exp Dermatol, vol. 18, 2009, p.553-561
  • 38. Kelishadi, R.& Gidding, S.S.& Hashemi, M.& Hashemipour, M.& Zakerameli, A.& Poursafa, P., "Acute and long term effects of grape and pomegranate juice consumption on endothelial dysfunction in pediatric metabolic syndrome", J Res Med Sci, vol. 16, 2011, p.245-253
  • 39. Kote, S.& Nagesh, L., "Effect of pomegranate juice on dental plaque microorganisms (streptococci and lactobacilli)", Anc Sci Life, vol. 31, 2011, p.49-51
  • 40. Nagata, M.& Hidaka, M.& Sekiya, H.& Kawano, Y.& Yamasaki, K.& Okumura, M. et al., "Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats", Drug Metab Dispos, vol. 35, 2007, p.302-305
  • 41. Mohan, M.& Waghulde, H.& Kasture, S., "Effect of pomegranate juice on Angiotensin II-induced hypertension in diabetic Wistar rats", Phytother Res, vol. 24, Suppl 2, 2010, p.S196-S203
  • 42. Rozenberg, O.& Howell, A.& Aviram, M., "Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it", Atherosclerosis, vol. 188, 2006, p.68-76
  • 43. de Nigris, F.& Balestrieri, M.L.& Williams-Ignarro, S.& D'Armiento, F.P.& Fiorito, C.& Ignarro, L.J. et al., "The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats", Nitric Oxide, vol. 17, 2007, p.50-54
  • 44. Vroegrijk, I.O.& van Diepen, J.A.& van den Berg, S.& Westbroek, I.& Keizer, H.& Gambelli, L. et al., "Pomegranate seed oil, a rich source of punicic acid, prevents diet-induced obesity and insulin resistance in mice", Food Chem Toxicol, vol. 49, 2011, p.1426-1430
  • 45. Meerts, I.A.& Verspeek-Rip, C.M.& Buskens, C.A.& Keizer, H.G.& Bassaganya-Riera, J.& Jouni, Z.E. et al., "Toxicological evaluation of pomegranate seed oil", Food Chem Toxicol, vol. 47, 2009, p.1085-1092
  • 46. Bassaganya-Riera, J.& DiGuardo, M.& Climent, M.& Vives, C.& Carbo, A.& Jouni, Z.E. et al., "Activation of PPARgamma and delta by dietary punicic acid ameliorates intestinal inflammation in mice", Br J Nutr, vol. 106, 2011, p.878-886
  • 47. Esmaillzadeh, A.& Tahbaz, F.& Gaieni, I.& Alavi-Majd, H.& Azadbakht, L., "Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia", J Med Food, vol. 7, 2004, p.305-308
  • 48. Szuchman, A.& Aviram, M.& Musa, R.& Khatib, S.& Vaya, J., "Characterization of oxidative stress in blood from diabetic vs. hypercholesterolaemic patients, using a novel synthesized marker", Biomarkers, vol. 13, 2008, p.119-131
  • 49. Fenercioglu, A.K.& Saler, T.& Genc, E.& Sabuncu, H.& Altuntas, Y., "The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 diabetes mellitus without complications", J Endocrinol Invest, vol. 33, 2010, p.118-124
  • 50. Aviram, M.& Rosenblat, M., "Pomegranate protection against cardiovascular diseases", Evid Based Complement Alternat Med, vol. 2012, 2012, p.382763
  • 51. Hunt, J.V.& Smith, C.C.& Wolff, S.P., "Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose", Diabetes, vol. 39, 1990, p.1420-1424
  • 52. Bierhaus, A.& Chevion, S.& Chevion, M.& Hofmann, M.& Quehenberger, P.& Illmer, T. et al., "Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells", Diabetes, vol. 46, 1997, p.1481-1490
  • 53. Myint, T.& Hoshi, S.& Ookawara, T.& Miyazawa, N.& Suzuki, K.& Taniguchi, N., "Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG", Biochim Biophys Acta, vol. 1272, 1995, p.73-79
  • 54. Kaneto, H.& Fujii, J.& Myint, T.& Miyazawa, N.& Islam, K.N.& Kawasaki, Y. et al., "Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction", Biochem J, vol. 320, Pt 3, 1996, p.855-863
  • 55. Tzulker, R.& Glazer, I.& Bar-Ilan, I.& Holland, D.& Aviram, M.& Amir, R., "Antioxidant activity, polyphenol content, and related compounds in different fruit juices and homogenates prepared from 29 different pomegranate accessions", J Agric Food Chem, vol. 55, 2007, p.9559-9570
  • 56. Donath, M.Y.& Shoelson, S.E., "Type 2 diabetes as an inflammatory disease", Nat Rev Immunol, vol. 11, 2011, p.98-107
  • 57. Houseknecht, K.L.& Cole, B.M.& Steele, P.J., "Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review", Domest Anim Endocrinol, vol. 22, 2002, p.1-23
  • 58. Francis, G.A.& Annicotte, J.S.& Auwerx, J., "PPAR agonists in the treatment of atherosclerosis", Curr Opin Pharmacol, vol. 3, 2003, p.186-191
  • 59. Bloom, A., "Obesity and diabetes; a review", Postgrad Med J, vol. 47, Suppl, 1971, p.430-434
  • 60. Springer, S.C.& Silverstein, J.& Copeland, K.& Moore, K.R.& Prazar, G.E.& Raymer, T. et al., "Management of type 2 diabetes mellitus in children and adolescents", Pediatrics, vol. 131, 2013, p.e648-e664
  • 61. Steppan, C.M.& Bailey, S.T.& Bhat, S.& Brown, E.J.& Banerjee, R.R.& Wright, C.M. et al., "The hormone resistin links obesity to diabetes", Nature, vol. 409, 2001, p.307-312
  • 62. McTernan, P.G.& Fisher, F.M.& Valsamakis, G.& Chetty, R.& Harte, A.& McTernan, C.L. et al., "Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes", J Clin Endocrinol Metab, vol. 88, 2003, p.6098-6106
  • 63. Kuzuya, T.& Nakagawa, S.& Satoh, J.& Kanazawa, Y.& Iwamoto, Y.& Kobayashi, M. et al., "Report of the committee on the classification and diagnostic criteria of diabetes mellitus", Diabetes Res Clin Pract, vol. 55, 2002, p.65-85
  • 64. Puavilai, G.& Chanprasertyotin, S.& Sriphrapradaeng, A., "Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization", Diabetes Res Clin Pract, vol. 44, 1999, p.21-26
  • 65. Tominaga, M., "Diagnostic criteria for diabetes mellitus", Rinsho Byori, vol. 47, 1999, p.901-908
  • 66. Grossmann, M.E.& Mizuno, N.K.& Schuster, T.& Cleary, M.P., "Punicic acid is an omega-5 fatty acid capable of inhibiting breast cancer proliferation", Int J Oncol, vol. 36, 2010, p.421-426
  • 67. Benalla, W.& Bellahcen, S.& Bnouham, M., "Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors", Curr Diabetes Rev, vol. 6, 2010, p.247-254
  • 68. Bektas, N.& Ozturk, Y., "Effect of phenolic acids on functions of rat aorta, vas deferens and on metabolic changes in streptozotocin-induced diabetes", Indian J Pharmacol, vol. 44, 2012, p.184-188
  • 69. Bolton, R.P.& Heaton, K.W.& Burroughs, L.F., "The role of dietary fiber in satiety, glucose, and insulin: studies with fruit and fruit juice", Am J Clin Nutr, vol. 34, 1981, p.211-217
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.